Fluxergy Inc

Startup
Summarized by Halo AI

Fluxergy is a healthcare technology company that provides a multimodal point-of-care diagnostic platform. Its system integrates molecular, immunoassay, cytometry, and clinical chemistry testing into a single, scalable, and affordable device.

Founded & HQ
Irvine, California, USA
Company size
51-200 employees
Funding
~$50M
IP status
25 patents filed · 1 grant confirmed
Activity highlights
Partnered with the Austere environments Consortium for Enhanced Sepsis Outcomes (ACESO) under a US Department of Defense grant to develop rapid point-of-care sepsis diagnostics.

Fluxergy is a biotechnology company based in Irvine, California, that provides a multimodal diagnostic platform designed for point-of-care testing. The company’s system integrates multiple diagnostic technologies—including molecular (PCR), immunochemistry, cytometry, and electrochemistry—onto a single, compact analyzer. Its proprietary test cards utilize a modular microfluidic chip design, allowing for versatility in testing applications while remaining cost-effective through automated, high-throughput manufacturing processes. The platform also includes FluxergyWorks, a middleware software solution that enables data management and seamless integration with Electronic Medical Record (EMR) and Laboratory Information Management (LIMS) systems.

By consolidating several diagnostic modalities into one platform, Fluxergy aims to deliver fast, accurate, and affordable health insights directly at the point of care. This approach is intended to empower clinicians and caregivers to make informed, real-time patient care decisions, helping to bridge the gap between complex laboratory testing and on-site clinical needs. Furthermore, the company offers its platform as an open OEM solution, partnering with developers to enable them to bring new assays to market more efficiently. With a 70,000-square-foot facility dedicated to technology innovation and microfluidic manufacturing, Fluxergy emphasizes scalable production capabilities to meet diagnostic demand.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

EM
Eric Mendonsa
Business Development Principal
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.